"FDA's Proposed Hatch-Waxman Updates – Implications for Generics and Beyond," Northwestern Journal of Technology and Intellectual Property Symposium, Northwestern School of Law, Chicago, IL
Speaking Engagement | 03.11.16
Contacts
Insights
Speaking Engagement | 10.15.25
“CMS ramps up scrutiny on improper payments: What plans need to know,” Becker’s Hospital Review